Brooklyn Health Raises $6.5M to Pioneer Precision Neuroscience through Objective Health Measurement

Brooklyn Health is thrilled to announce a successful funding round that raised $6,500,000, marking a significant milestone in our journey to revolutionize healthcare through precision neuroscience.

At Brooklyn Health, we’re committed to solving the measurement problem in health by providing accurate, sensitive, and objective measurements that are crucial for both clinical research and patient care.

This new capital injection will accelerate our development of cutting-edge measurement technologies and expand our clinical trials, ensuring that we continue to break new ground in precision neuroscience.

The funds are earmarked for scaling our innovative platform, enhancing our research capabilities, and fostering strategic collaborations with academic institutions and healthcare providers.

These investments will directly support our initiatives to integrate objective measurement tools within clinical environments, delivering more personalized and data-driven treatment options for patients.

Additionally, the raised funds will help expand our talent pool by recruiting experts in biomedical engineering, data analytics, and neuroscience, further strengthening our multidisciplinary approach to bridging the gap between clinical research and practical patient care.

This exciting funding accomplishment underscores the confidence that investors have in our vision to transform the landscape of healthcare, paving the way for advancements that could redefine how neurological and neurodegenerative conditions are diagnosed and treated.

As we continue to advance our mission with renewed vigor and additional resources, we remain dedicated to empowering clinicians and researchers with the tools they need to achieve breakthroughs that will ultimately lead to improved patient outcomes and healthier communities.